TrueScale Capitals leads Series B2 funding for Advamedica Posted on July 27, 2021 Boston, 27th July 2021: Advamedica has raised $6 million in a Series B2 funding round led by TrueScale Continue Reading
Advamedica Receives FDA Clearance for Axiostat Hemostatic Patch Posted on July 1, 2021 A biomaterial-focused MedTech startup has announced FDA 510(k) clearance of its hemostatic product... Continue Reading
Advamedica selected to pitch for Medtech Innovator US Military Pitch Posted on February 20, 2020 Advamedica has been selected for MedTech Innovator US Military Pitch (May 2020) to pitch its Military... Continue Reading
Omidyar Network leads Series B1 funding for Advamedica Posted on January 9, 2020 Advamedica has raised $5.2 Mn in Series B1 round of funding led by Omidyar Network, along with participation... Continue Reading
Advamedica announces world-class scientific advisory board Posted on March 14, 2019 Advamedica has announced its top-notch scientific advisory board and research collaboration... Continue Reading
Axiostat receives US FDA clearance Posted on February 28, 2018 US FDA granted 510(k) clearance to Axiostat Chitosan Hemostatic Dressing, which is cleared... Continue Reading
University of California Series B round of funding for Advamedica Posted on January 26, 2018 Advamedica has raised $7.4 million Series B funding led by UC-RNT fund -- set up by the University... Continue Reading